Search for other papers by Hiroyuki Iwaki in
Google Scholar
PubMed
Search for other papers by Kenji Ohba in
Google Scholar
PubMed
Search for other papers by Eisaku Okada in
Google Scholar
PubMed
Search for other papers by Takeshi Murakoshi in
Google Scholar
PubMed
Search for other papers by Yumiko Kashiwabara in
Google Scholar
PubMed
Search for other papers by Chiga Hayashi in
Google Scholar
PubMed
Search for other papers by Akio Matsushita in
Google Scholar
PubMed
Search for other papers by Shigekazu Sasaki in
Google Scholar
PubMed
Search for other papers by Takafumi Suda in
Google Scholar
PubMed
Search for other papers by Yutaka Oki in
Google Scholar
PubMed
Search for other papers by Rieko Gemma in
Google Scholar
PubMed
dosage that ensures maternal serum free thyroxine (FT4) levels at or moderately above the upper limit of the reference range is reported to be appropriate for fetal euthyroid status [ 2 ]. This recommendation was incorporated into the 2017 American
Search for other papers by Pei-Wen Wang in
Google Scholar
PubMed
Search for other papers by I-Ya Chen in
Google Scholar
PubMed
Search for other papers by Suh-Hang Hank Juo in
Google Scholar
PubMed
Search for other papers by Edward Hsi in
Google Scholar
PubMed
Search for other papers by Rue-Tsuan Liu in
Google Scholar
PubMed
Search for other papers by Ching-Jung Hsieh in
Google Scholar
PubMed
Introduction For patients with Graves’ disease (GD), there are three choices of treatment, none of which is perfect. The primary goal of antithyroid drug therapy is to temporarily restore the patient to the euthyroid state while awaiting a
Department of Clinical Institute, Aalborg University, Aalborg, Denmark
Search for other papers by Allan Carlé in
Google Scholar
PubMed
Search for other papers by Nils Knudsen in
Google Scholar
PubMed
Department of Public Health, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Torben Jørgensen in
Google Scholar
PubMed
Search for other papers by Bettina Thuesen in
Google Scholar
PubMed
Department of Clinical Institute, Aalborg University, Aalborg, Denmark
Search for other papers by Jesper Karmisholt in
Google Scholar
PubMed
Department of Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark
Search for other papers by Stine Linding Andersen in
Google Scholar
PubMed
Department of Clinical Institute, Aalborg University, Aalborg, Denmark
Search for other papers by Inge Bülow Pedersen in
Google Scholar
PubMed
study period spanned from March 1997 to December 2000. This encompassed 1,055,608 years of observation. For case-control analyses, we recruited euthyroid subjects randomly selected from the same population. Patients Two geographical areas were
Search for other papers by Georgios K. Markantes in
Google Scholar
PubMed
Search for other papers by Marina A. Michalaki in
Google Scholar
PubMed
Search for other papers by George A. Vagenakis in
Google Scholar
PubMed
Search for other papers by Fotini N. Lamari in
Google Scholar
PubMed
Search for other papers by Efthymia Pitsi in
Google Scholar
PubMed
Search for other papers by Maria Eliopoulou in
Google Scholar
PubMed
Search for other papers by Nicholas G. Beratis in
Google Scholar
PubMed
Search for other papers by Kostas B. Markou in
Google Scholar
PubMed
): patients diagnosed with subacute thyroiditis, who had never used amiodarone. Group Control ( n = 21): euthyroid subjects, without history of thyroid disease or amiodarone use, with normal levels of thyroid function tests. Thyroid imaging was performed in
Search for other papers by Emna Jelloul in
Google Scholar
PubMed
Search for other papers by Georgiana Sitoris in
Google Scholar
PubMed
Search for other papers by Flora Veltri in
Google Scholar
PubMed
Search for other papers by Pierre Kleynen in
Google Scholar
PubMed
Search for other papers by Serge Rozenberg in
Google Scholar
PubMed
Search for other papers by Kris G Poppe in
Google Scholar
PubMed
pregnancy in euthyroid women . Best Practice and Research. Clinical Endocrinology and Metabolism 2023 37 101632 . ( https://doi.org/10.1016/j.beem.2022.101632 ) 21 Benson AE Shatzel JJ Ryan KS Hedges MA Martens K Aslan JE & Lo JO . The
Search for other papers by Toshihide Yamamoto in
Google Scholar
PubMed
were measured 3 months after dosage adjustment. Doses to keep serum TSH levels within the reference range were maintained. All of them had stayed in a euthyroid state and had never been treated with medication containing glucocorticoids (GC). Seven
Search for other papers by Roberto Negro in
Google Scholar
PubMed
Search for other papers by Roberto Attanasio in
Google Scholar
PubMed
Search for other papers by Franco Grimaldi in
Google Scholar
PubMed
Search for other papers by Andrea Frasoldati in
Google Scholar
PubMed
Search for other papers by Rinaldo Guglielmi in
Google Scholar
PubMed
Search for other papers by Enrico Papini in
Google Scholar
PubMed
249 euthyroid patients with benign uni-multinodular goiters, one-fourth of the patients experienced a significant event, such as new nodule appearance, a nodule diameter increase of >50%, appearance of compressive symptoms, thyroidectomy, FNA
Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
Search for other papers by Stine Linding Andersen in
Google Scholar
PubMed
Search for other papers by Niels Henrik Bruun in
Google Scholar
PubMed
Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
Search for other papers by Peter Astrup Christensen in
Google Scholar
PubMed
Search for other papers by Simon Lykkeboe in
Google Scholar
PubMed
Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
Search for other papers by Aase Handberg in
Google Scholar
PubMed
Search for other papers by Annebirthe Bo Hansen in
Google Scholar
PubMed
Search for other papers by Maja Hjelm Lundgaard in
Google Scholar
PubMed
Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
Search for other papers by Louise Knøsgaard in
Google Scholar
PubMed
Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
Search for other papers by Nanna Maria Uldall Torp in
Google Scholar
PubMed
Department of Endocrinology, Aalborg University Hospital, Aalborg, Denmark
Search for other papers by Allan Carlé in
Google Scholar
PubMed
Department of Endocrinology, Aalborg University Hospital, Aalborg, Denmark
Search for other papers by Jesper Karmisholt in
Google Scholar
PubMed
Department of Endocrinology, Aalborg University Hospital, Aalborg, Denmark
Search for other papers by Inge Bülow Pedersen in
Google Scholar
PubMed
Department of Endocrinology, Aalborg University Hospital, Aalborg, Denmark
Steno Diabetes Center North Jutland, Aalborg University Hospital, Aalborg, Denmark
Search for other papers by Peter Vestergaard in
Google Scholar
PubMed
Department of Geriatrics, Aalborg University Hospital, Aalborg, Denmark
Search for other papers by Stig Andersen in
Google Scholar
PubMed
). However, the scientific focus on pregnant women has moved beyond overt hypothyroidism toward smaller abnormalities in maternal thyroid function. Furthermore, the role of thyroid autoimmunity per se is considered, and treatment of euthyroid pregnant women
Azienda USL, Modena, Italy
Search for other papers by Giulia Brigante in
Google Scholar
PubMed
Azienda USL, Modena, Italy
Search for other papers by Giorgia Spaggiari in
Google Scholar
PubMed
Azienda USL, Modena, Italy
Search for other papers by Daniele Santi in
Google Scholar
PubMed
Azienda USL, Modena, Italy
Search for other papers by Katia Cioni in
Google Scholar
PubMed
Azienda USL, Modena, Italy
Search for other papers by Valentina Gnarini in
Google Scholar
PubMed
Azienda USL, Modena, Italy
Search for other papers by Chiara Diazzi in
Google Scholar
PubMed
Center of Genomic Research, University of Modena and Reggio Emilia
Search for other papers by Elisa Pignatti in
Google Scholar
PubMed
Center of Genomic Research, University of Modena and Reggio Emilia
Search for other papers by Livio Casarini in
Google Scholar
PubMed
Center of Genomic Research, University of Modena and Reggio Emilia
Search for other papers by Marco Marino in
Google Scholar
PubMed
Search for other papers by Frank Tüttelmann in
Google Scholar
PubMed
Azienda USL, Modena, Italy
Search for other papers by Cesare Carani in
Google Scholar
PubMed
Center of Genomic Research, University of Modena and Reggio Emilia
Azienda USL, Modena, Italy
Search for other papers by Manuela Simoni in
Google Scholar
PubMed
) produced in the hypothalamus stimulates biosynthesis and secretion of TSH from the pituitary [ 27 ], which in turn stimulates biosynthesis of thyroid hormones [ 28 ]. The maintenance of euthyroidism is dependent on TRH regulation of TSH synthesis and
Search for other papers by Joke Marlier in
Google Scholar
PubMed
Department of Internal Medicine & Pediatrics, Ghent University, Ghent, Belgium
Search for other papers by Guy T’Sjoen in
Google Scholar
PubMed
Department of Internal Medicine & Pediatrics, Ghent University, Ghent, Belgium
Search for other papers by Jean Kaufman in
Google Scholar
PubMed
Department of Internal Medicine & Pediatrics, Ghent University, Ghent, Belgium
Search for other papers by Bruno Lapauw in
Google Scholar
PubMed
1 (see section on supplementary materials given at the end of this article). Patients with PHT should be euthyroid (TSH levels between 0.2 and 4.5 mU/L). Only patients using the l -thyroxine® brand of LT4 (Takeda) were included. Patients using